Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Marteau · SciRah

Researcher profile · Semantic Scholar

F. Marteau

Share profile

F. Marteau — researcher profile on SciRah

h-index: 11
Works: 45
Citations: 489

Most-cited papers

Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.
E. Hollander, D. Stein, N. Fineberg, F. Marteau +1 more
2010Journal of Clinical Psychiatry111 citations
Semantic Scholar
Side‐effects of antipsychotic medication and health‐related quality of life in schizophrenia
P. Bebbington, M. Angermeyer, J. Azorin, Steven Marwaha +2 more
2009Acta Psychiatrica Scandinavica Supplementum71 citations
Semantic Scholar
Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.
D. Cella, B. Escudier, N. Tannir, T. Powles +17 more
2018Journal of Clinical Oncology51 citations Open access
Semantic Scholar
Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma
R. Kelley, P. Mollon, J. Blanc, B. Daniele +6 more
2020Advances in Therapy47 citations Open access
Semantic Scholar
Carcinoid Heart Disease: Prognostic Value of 5-Hydroxyindoleacetic Acid Levels and Impact on Survival: A Systematic Literature Review
A. Buchanan-Hughes, A. Pashley, M. Feuilly, F. Marteau +2 more
2020Neuroendocrinology29 citations Open access
Semantic Scholar
Relationship Between Symptoms and Health-related Quality-of-life Benefits in Patients With Carcinoid Syndrome: Post Hoc Analyses From TELESTAR.
D. Cella, J. Beaumont, S. Hudgens, F. Marteau +7 more
2018Clinical Therapeutics27 citations Open access
Semantic Scholar
[Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France].
M. Rouprêt, B. Malavaud, Laurent Molinier, H. Leleu +2 more
2015Progrès en urologie (Paris)14 citations
Semantic Scholar
Quality‐adjusted survival with first‐line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance)
Ronald C. Chen, T. Choueiri, M. Feuilly, J. Meng +6 more
2020Cancer13 citations Open access
Semantic Scholar
Cost-effectiveness of escitalopram in major depressive disorder in the Dutch health care setting.
M. Nuijten, M. Brignone, F. Marteau, J. D. den Boer +1 more
2012Clinical Therapeutics12 citations
Semantic Scholar
Cost-effectiveness evaluation in Sweden of escitalopram compared with venlafaxine extended-release as first-line treatment in major depressive disorder.
G. Nordström, N. Danchenko, N. Despiégel, F. Marteau
2012Value in Health12 citations Open access
Semantic Scholar
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison
J. Trojan, P. Mollon, B. Daniele, F. Marteau +8 more
2021Advances in Therapy11 citations Open access
Semantic Scholar
Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-Analysis
E. Schmidt, J. Lister, M. Neumann, W. Więcek +5 more
2018Targeted oncology11 citations Open access
Semantic Scholar
Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden
G. Nordström, N. Despiégel, F. Marteau, N. Danchenko +1 more
2010Journal of Medical Economics11 citations Open access
Semantic Scholar
Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study
Eva Lesén, A. Bjorstad, I. Björholt, T. Marlow +6 more
2018Scandinavian Journal of Gastroenterology10 citations Open access
Semantic Scholar
Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index
S. Shaunfield, K. Webster, Karen Kaiser, George J. Greene +9 more
2020Neuroendocrinology9 citations
Semantic Scholar
Epidemiology of Patients with Metastatic Castrate Resistant Prostate Cancer in Europe and Australia.
F. Marteau, G. Gimonet, S. Gabriel, J. Dinet +2 more
2014Value in Health8 citations Open access
Semantic Scholar
Cabozantinib versus other TKIs after CPI treatment in the real-world management of patients with metastatic renal cell carcinoma (mRCC).
F. Marteau, B. Harrow, C. McCarthy, J. Wallace +3 more
20217 citations
Semantic Scholar
Quality-adjusted time without symptoms or toxicity (Q-TWiST): Analysis of cabozantinib (Cabo) vs sunitinib (Sun) in patients with advanced renal cell carcinoma (aRCC) of intermediate or poor risk (Alliance A031203).
Ronald C. Chen, M. Feuilly, J. Meng, J. Lister +4 more
20186 citations
Semantic Scholar
Comparative efficacy of cabozantinib and ramucirumab after sorafenib for patients with advanced hepatocellular carcinoma and AFP ≥ 400 ng/ml
M. Venerito, J. Trojan, P. Mollon, B. Daniele +8 more
2021Zeitschrift für Gastroenterologie - German Journal of Gastroenterology5 citations
Semantic Scholar
Cost-Effectiveness of the Optical Imaging Agent Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer
F. Marteau, A. Kornowski, C. Bennison, M. Tempest +2 more
20135 citations Open access
Semantic Scholar
Kosten-Effektivitäts-Analyse zur Verwendung der Blaulichtzystoskopie mit Hexylaminolevulinat bei der transurethralen Resektion der Harnblase
G. Gakis, B. Volkmer, B. Qvick, F. Marteau +1 more
2018Der Urologe4 citations
Semantic Scholar
A Budget Impact Model of the Addition of Telotristat Ethyl Treatment to the Standard of Care in Patients with Uncontrolled Carcinoid Syndrome
K. Fust, M. Maschio, M. Kohli, S. Singh +4 more
2020PharmacoEconomics (Auckland)3 citations Open access
Semantic Scholar
O1 Cost-effectiveness of the optical imaging agent hexaminolevulinate for patients undergoing initial transurethral resection of non-muscle invasive bladder cancer tumours
F. Marteau, A. Kornowski, C. Bennison, M. Tempest +2 more
20133 citations
Semantic Scholar
ECOG score analysis as a proxy for health-related quality of life assessment in patients with poor or intermediate risk metastatic renal cell carcinoma from the CABOSUN trial (Alliance A031203).
D. Feldman, M. Feuilly, J. Meng, J. Lister +4 more
20182 citations
Semantic Scholar
Cost-Utility of Hexaminolevulinate Blue Light Cystoscopy (Hal) Assisted Transurethral Resection of The Bladder Tumour (Turb) Compared to Turb With White Light Cystoscopy (Wlc) Alone In Patients With Non-Muscle Invasive Bladder Cancer (Nimbc) In Poland.
Z. Jabłonowski, T. Konecki, M. Ziobro, M. Hałdaś +3 more
2015Value in Health2 citations Open access
Semantic Scholar
P.4.a.001 Quality of life outcomes in obsessive-compulsive disorder: relationship to treatment response and symptom relapse
N. Fineberg, D. J. Stein, M. Legault, F. Marteau +1 more
20102 citations
Semantic Scholar
Cabozantinib versus other TKIs after CPI treatment in the real-world management of patients with mRCC.
F. Marteau, B. Harrow, C. McCarthy, J. Wallace +3 more
20211 citations
Semantic Scholar
PDG12 In the Current COVID Reality, CAN Independent Injection of Somatostatin Snalogues Lead to Greater Health Savings? a Budget IMPACT Analysis in the UK
B. Harrow, O. Cristeau, E. Clay, C. François +2 more
20201 citations Open access
Semantic Scholar
445PRelationship between symptoms and health-related quality of life benefits in patients with carcinoid syndrome: Post-hoc analyses from TELESTAR
M. Pavel, D. Cella, J. Beaumont, S. Hudgens +7 more
20171 citations Open access
Semantic Scholar
Real-World Resource Use And Costs Of Carcinoid Heart Disease In Patients With Neuroendocrine Tumors : A Retrospective Swedish Study
A. Bjorstad, T. Marlow, Eva Lesén, E. Bollano +4 more
20171 citations Open access
Semantic Scholar
Quality-adjusted time without symptoms of disease progression or toxicity (Q-TWiST) of nivolumab plus cabozantinib (N+C) versus sunitinib (SUN) in treatment-naïve, advanced/metastatic renal cell carcinoma (aRCC): A post-hoc analysis of CheckMate 9ER (CM 9ER) data.
D. Cella, R. Motzer, J. May, J. Wallace +6 more
2021Journal of Clinical Oncology0 citations
Semantic Scholar
PDG23 BUDGET IMPACT ANALYSIS OF SOMATOSTATIN ANALOGUES IN THE TREATMENT OF GEP-NET AND ACROMEGALY IN THE UK
M. Feuilly, O. Cristeau, E. Clay, C. François +3 more
2019Value in Health0 citations Open access
Semantic Scholar
PCN42 CABOZANTINIB VERSUS STANDARD-OF-CARE COMPARATORS: A NETWORK META-ANALYSIS OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN FIRST-LINE TREATMENT OF ADVANCED RENAL CELL CARCINOMA
J. Lister, S. Pafitas, J. Meng, Witold Wiecek +3 more
2019Value in Health0 citations Open access
Semantic Scholar
Cabozantinib Versus Standard of Care in the first-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma: A Network Meta-Analysis
J. Lister, E. Schmidt, F. Marteau, A. Vataire
20180 citations Open access
Semantic Scholar
443PIdentifying symptom and quality of life improvements in patients with carcinoid syndrome treated with telotristat ethyl: Qualitative patient exit interviews from the TELESTAR Trial
F. Marteau, P. Williams, M. Feuilly, B. Arnould
20170 citations Open access
Semantic Scholar
Relationship between symptoms and health-related quality of life benefits in patients with carcinoid syndrome: post-hoc analyses from TELESTAR
M. Pavel, D. Cella, J. Beaumont, S. Hudgens +7 more
20170 citations
Semantic Scholar
Real-World Resource Use And Costs Of Treating Controlled And Uncontrolled Carcinoid Syndrome: A Retrospective Swedish Study
Eva Lesén, A. Bjorstad, I. Björholt, M. Feuilly +5 more
20170 citations Open access
Semantic Scholar
Beziehung von Symptomen und den Vorteilen einer gesundheitsbezogenen Lebensqualität bei Patienten mit Karzinoid-Syndrom: Eine post-hoc-Analyse der Telotristat Ethyl-Studie TELESTAR
D. Hörsch, D. Cella, J. Beaumont, S. Hudgens +6 more
2017Zeitschrift für Gastroenterologie - German Journal of Gastroenterology0 citations
Semantic Scholar
Symptom Deterioration in Patients with Metastatic Renal Cell Carcinoma Treated with Cabozantinib or Everolimus
F. Marteau, J. Beaumont, S. Gabriel, M. Hankins +3 more
20170 citations Open access
Semantic Scholar
Impact médico-économique de la résection transurétrale de vessie (RTUV) en lumière bleue utilisant la fluorescence pour le traitement des tumeurs de la vessie n’infiltrant le muscle (TVNIM) en France
M. Rouprêt, B. Malavaud, L. Molinier, H. Leleu +2 more
2014Progrès en urologie (Paris)0 citations
Semantic Scholar
Prototype Model in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): A Tool to Position New Treatments in the Patient Pathway?
H. Karcher, J. Dinet, B. Amzal, F. Marteau +4 more
20130 citations Open access
Semantic Scholar
PMH45 Utility Scores Associated with the World Health Organisation Drinking Risk-Level Classification in Alcohol Dependence
T. Sanglier, P. Laramée, A. Millier, M. Guennec +2 more
20120 citations Open access
Semantic Scholar
ORIGINAL RESEARCH Economic Evaulation Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine Extended-Release as First-Line Treatment in Major Depressive Disorder
G. Nordström, N. Danchenko, N. Despiégel, F. Marteau +1 more
20120 citations
Semantic Scholar
PMH41 COST-UTILITY ANALYSIS OF ESCITALOPRAM VERSUS CITALOPRAM IN MAJOR DEPRESSIVE DISORDER IN ISRAEL
M. Leshno, Y. Ben-Amnon, M. Brignone, F. Marteau +1 more
20100 citations Open access
Semantic Scholar
PMH24 ECONOMIC BENEFITS OF ESCITALOPRAM VERSUS DULOXETINE IN SPAIN
N. Danchenko, N. Despiégel, F. Marteau, S. D. del Rey
20090 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Feuilly×13
Invite
M. Feuilly — researcher profile on SciRah
D. Cella×7
Invite
D. Cella — researcher profile on SciRah
S. Gabriel×7
Invite
S. Gabriel — researcher profile on SciRah
J. Lister×6
Invite
J. Lister — researcher profile on SciRah

×5

Invite

T. Choueiri — researcher profile on SciRah

Invite

J. Beaumont — researcher profile on SciRah

Invite

J. Meng — researcher profile on SciRah

N. Danchenko×4

Invite

N. Danchenko — researcher profile on SciRah

N. Despiégel×4

Invite

N. Despiégel — researcher profile on SciRah

Invite

P. Mollon — researcher profile on SciRah

Invite

B. Daniele — researcher profile on SciRah

Invite

S. Singh — researcher profile on SciRah